Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Angeion Corp. (ANGN) -- Ignore unavailable to you. Want to Upgrade?

To: RealTime who wrote (1037)	5/23/1999 4:11:00 PM
From: jean	Read Replies (1) \| Respond to of 1046

Thanks, RealTime. This is one I'll be eating for a long time. I was many thousands of shares long, and now I'm many, many thousands of dollars short. May I live long enough to find out what the real story is behind the demise of ANGN. Too much that's unknown now, but sooner or later, maybe we'll know what took this one to the toilet. In the meantime, lots of luck and good investing. Jean

To: RealTime who wrote (1037)	9/19/1999 9:16:00 PM
From: TheTruth000	Respond to of 1046

SS ANGN at any price : ANGN up 46% Friday due to CNBC mention and deal with Medtronic, in which Medtronic has a non-exclusive license to all of ANGN's patents. ANGN's realizes 9 million in cash from this deal. Company burning cash at a rate of over 1 million dollars per month. ANGN has already defaulted on $20 million dollars in debt. A $35 million dollar lawsuit settled in the spring makes it perfectly clear that if ANGN defaults on this debt, then they must dispose of all their assets or attempt a sale. A sale has been ruled out for the most part, due to the agreement with Medtronic. ANGN has nothing of any value to offer now. The company completed a 1 for 10 reverse split on May 18th to maintain its Nasdaq listing. After the bondholders are done with this company, there will be nothing left of it.